Cardiovascular Therapy and Prevention (Russian Federation)

Aims & Scope

The most important objectives of the journal are: the generalization of scientific and practical achievements in the field of cardiology, increasing scientific and practical skills of cardiologists.

The scientific concept of publication does the publication of modern achievements in the field of epidemiology, prevention and treatment of cardiovascular diseases, the results of research, national and international clinical trials.

For publication in the journal are invited both domestic and foreign scientists and clinicians working in the field of cardiology, as well as doctors of other specialties.

The magazine covers various issues in cardiology and related specialties.

Each issue is prepared by Executive editor of the issue, a respected specialist in the field of epidemiology, prevention and treatment of cardiovascular diseases.

The main focus of the publication — scientific articles on original research, the pharmacotherapy of cardiovascular disease, new diagnostic methods.

All members of the group of authors should meet all four criteria of authorship set forth in the ICMJE recommendations: 1) concept and design development or data analysis and interpretation, and 2) manuscript justification or verification of critical intellectual content, and 3) final approval for publication of the manuscript, and 4) consent to be responsible for all aspects of the work, and assume that issues relating to the thoroughness and diligent execution of any part of the study submitted are duly investigated and resolved.

Great importance the editors attached to the preparation of scientific papers by groups of authors at a high level, literacy, authors, and their ownership information, availability of research results not only to colleagues in Russia, but also abroad.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Social Sciences, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Social Sciences, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD

  Citation: 186

  Authors: S. A., Yu. A., S. A., A. D., G. V., T. M., D. V., A. Yu., Yu. V., A. O., R. A., A. V., S. V., E. V., S. A., O. P., I. A., I. E., E. V., G. A., S. E., A. V., V. V., R. G., M. N., E. I., O. A., O. A., G. I., N. I., O. G., L. V., A. E., A. A., E. V., E. N., I. R., V. Yu., E. A., D. V., A. E., E. V., N. V., S. A., Ya. V., T. A., S. V., I. V., V. G., M. A., G. V., Z. T., Z. A., V. S., R. S., V. N.

• THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RUSSIAN POPULATION IN 2012-2013 YEARS. THE RESULTS OF ECVD-RF

  Citation: 175

  Authors: G. A., A. V., V. V., G. V., T. M., D. V., A. Yu., Yu. V., V. A., A. O., R. A., E. V., S. V., E. V., S. V., O. P., I. A., A. D., S. A., I. E., E. V., S. A., Yu. A., N. V., S. E., A. V., O. A., M. N., V. A., R. G., E. I., M. B., E. I., R. A., A. A., A. A., E. V., O. G., N. I., L. V., G. I., A. E., O. A., O. A., E. A., O. L., Ya. V., E. V., S. A., T. A., A. E., N. V., I. R., E. N., V. Yu., E. A., D. V., S. A., N. A., V. S., R. S., V. N., I. V., M. A., V. P., S. V., S. K., G. V.

• Comorbidities in clinical practice. Algorithms for diagnostics and treatment

  Citation: 156

  Authors: R. G., V. I., I. G., N. V., O. L., S. A., S. A., N. P., V. L., A. E., Yu. V., A. M., M. M., T. E., A. P., M. M., Yu. M., A. V., A. V., O. N., S. A.

• Psychoemotional risk factors for non-communicable diseases in outpatient practice. Guidelines for internists

  Citation: 118

  Authors: O. M., V. M., M. B.

• Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later

  Citation: 92

  Authors: S. A., O. M., E. V., A. O., Yu. A., Yu. V., V. A., E. V., O. P., S. A.

• COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES

  Citation: 90

  Authors: R. G., I. N., V. I., I. G., N. V., S. A., O. N, N. P, V. L, O. M., E. N., Yu. V., A. M., M. N., B. U., O. N., M. M., Yu. M., N. K., S. A., A. V., O. N., A. M., S. A.

• 2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines

  Citation: 79

  Authors: O. M., A. V., A. M., S. M., M. V., L. M., A. A., D. M., N. M., Yu. A., T. V., S. A., M. V., E. V., M. V., A. V., M. G., V. M., B. E., A. Yu., N. G., V. A., L. Yu., V. A., S. O., A. I., E. S., A. E., P. V., A. D., N. S., Zh. D., A. O., O. V., L. S., M. B., M. S., E. A., O. V., M. V., Yu. V., M. M., I. V., M. N., S. V., S. Yu., V. A., A. N., O. Yu., D. K., A. O., D. V., D. O., E. A., M. V., O. E., V. I., G. G., Yu. S., O. P., I. A., Yu. V., I. A., N. A., M. I., V. V., S. N., E. V., Zh. V., S. A., R. N., V. N., I. S.

• Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice

  Citation: 77

  Authors: Yu. A., S. V., E. L., Yu. V., V. A., V. E., Ya. A., A. N., A. A., S. A., A. S., Zh. D., O. V., A. O., Yu. M., V. Yu., D. S., R. G., A. N., O. P., N. V., V. V.

• Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus

  Citation: 77

  Authors: V. I., I. V., O. N., S. A., D. N., D. S., T. D., N. M., V., I. V., M. Yu., N. S., А. E., Yu. V., Iu. A., G. G., E. V., A. M., M. V., E. A., T. V., O. A., O. I., A. N., G. N., D. I., A. V.

• Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020

  Citation: 69

  Authors: V. B., I. V., V. L., Yu. V., Yu. A., V. I., E. I., A. V., A. V., A. I., O. N., D. I.